Benzyl N-[(3-oxocyclobutyl)methyl]carbamate, 98%, 1g

(R)-2-Amino-2-(bicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride, 98%, 500mg

N-Methyl 2-bromo-4-fluoroaniline, HCl, 97%, 1g

tert-Butyl 3-(2-(2-bromoethoxy)ethoxy)propanoate, 95.0%, 5g

3-Methyl-2-pentanol (mixture of diastereoisomers)>98.0%(GC)25mL

13 liter round bucket PP white round

(S)-3-Amino-1-ethyl-2-azepanone, 95.0%, 5g

(3-bromophenoxy)acetic acid, 95.0%, 25g

(R)-1-(2-bromo-5-fluorophenyl)ethan-1-ol, 250mg

tert-Butyl 3-(3-amino-1H-pyrazol-1-yl)azetidine-1-carboxylate, 98%, 100mg

Plan PLPH 10x/0.25 phase contrast objective

(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)methanol, 95.0%, 250mg

tert-Butyl (4-methylpiperidin-4-yl)methylcarbamate, 95.0%, 250mg